MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacc.2025.11.032

Медицинская библиотека · Journal of the American College of Cardiology · 2026

Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial.

van Steijn Nicole J, Blommestijn Isabel S, Blok Sebastiaan, Pepplinkhuizen Shari, Somsen G Aernout, Knops Reinoud E, Breukel Laura, Tijssen Jan G P, Tulevski Igor I, Croon Philip M, Winter Michiel M

СтатьяРандомизированное исследованиеМногоцентровое исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Atrial fibrillation (AF), the most common cardiac arrhythmia, is a major cause of stroke and often remains undiagnosed due to its paroxysmal and frequently asymptomatic nature. Wearables provide a scalable, noninvasive screening tool.

OBJECTIVES

This trial evaluated new onset AF detection in patients at elevated stroke risk using remote smartwatch-based screening.

METHODS

This prospective multicenter randomized controlled trial included patients ≥65 years with elevated stroke risk (CHA2DS2-VASc ≥2 men, ≥3 women) from 2 secondary care centers in the Netherlands. Patients were randomized to 6-month (180-day) monitoring with a smartwatch with photoplethysmography and single-lead electrocardiogram (ECG) functions, or standard care. ECGs were reviewed remotely by an independent eHealth team within 24 hours. The primary outcome was new onset AF, defined as a confirmed episode lasting ≥30 seconds on single-lead ECG or standard ECG methods.

RESULTS

Between November 2022 and December 2023, 437 patients were randomized (219 intervention, 218 control); the median age was 75 years, 46.7% were female and the median CHA2DS2-VASc score was 3.0. New onset AF occurred in 21 (9.6%) patients of the intervention group and 5 (2.3%) patients of the control group (risk difference: 7.3 percentage points; 95% CI: 2.9-11.7 percentage points; P = 0.001; HR: 4.40; 95% CI: 1.66-11.66). Several asymptomatic AF episodes were detected only in the intervention group, while paroxysmal AF occurred in both groups.

CONCLUSIONS

This randomized controlled trial provides evidence that 6-month smartwatch-based AF screening enhances the detection rate of new onset AF compared with standard care in patients at elevated stroke risk. (Detection and Quantification of Atrial Fibrillation in High-risk Patients Using a Smartwatch Wearable [Apple Watch] [EQUAL]; NCT05686330).

Для цитирования: van Steijn Nicole J, Blommestijn Isabel S, Blok Sebastiaan, Pepplinkhuizen Shari, Somsen G Aernout, Knops Reinoud E, Breukel Laura, Tijssen Jan G P, Tulevski Igor I, Croon Philip M, Winter Michiel M. Enhanced Detection and Prompt Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial.. Journal of the American College of Cardiology. 2026. DOI: 10.1016/j.jacc.2025.11.032.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.